Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Nowak

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Pharmacological Reports : PR|May 3, 2015
Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant actionGabriel Nowak
Polish Journal of Pharmacology|July 18, 2003
Mechanisms contributing to antidepressant zinc actionsGabriel Nowak, Bernadeta Szewczyk
Pharmacological Reports : PR|June 5, 2012
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressantsKatarzyna Młyniec, Gabriel Nowak
Pharmacological Reports : PR|October 21, 2015
Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient miceKatarzyna Młyniec, Gabriel Nowak
Neurochemistry International|March 12, 2013
GPR39 up-regulation after selective antidepressantsKatarzyna Młyniec, Gabriel Nowak
Drugs of Today (Barcelona, Spain : 1998)|January 6, 2006
GABAergic hypotheses of anxiety and depression: focus on GABA-B receptorsAndrzej Pilc, Gabriel Nowak
Pharmacological Reports : PR|June 29, 2016
Brain glutamic acid decarboxylase-67kDa alterations induced by magnesium treatment in olfactory bulbectomy and chronic mild stress models in ratsBartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk
Expert Review of Neurotherapeutics|July 23, 2019
An update on NMDA antagonists in depressionBartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk
Brain Research Bulletin|February 7, 2021
Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depressionDominika Siodłak, Gabriel Nowak, Katarzyna Mlyniec
Behavioural Brain Research|April 2, 2015
Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonistsKatarzyna Młyniec, Magdalena Gaweł, Gabriel Nowak
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Pharmacological Reports : PR|May 3, 2015
Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant actionGabriel Nowak
Polish Journal of Pharmacology|July 18, 2003
Mechanisms contributing to antidepressant zinc actionsGabriel Nowak, Bernadeta Szewczyk
Pharmacological Reports : PR|June 5, 2012
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressantsKatarzyna Młyniec, Gabriel Nowak
Pharmacological Reports : PR|October 21, 2015
Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient miceKatarzyna Młyniec, Gabriel Nowak
Neurochemistry International|March 12, 2013
GPR39 up-regulation after selective antidepressantsKatarzyna Młyniec, Gabriel Nowak
Drugs of Today (Barcelona, Spain : 1998)|January 6, 2006
GABAergic hypotheses of anxiety and depression: focus on GABA-B receptorsAndrzej Pilc, Gabriel Nowak
Pharmacological Reports : PR|June 29, 2016
Brain glutamic acid decarboxylase-67kDa alterations induced by magnesium treatment in olfactory bulbectomy and chronic mild stress models in ratsBartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk
Expert Review of Neurotherapeutics|July 23, 2019
An update on NMDA antagonists in depressionBartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk
Brain Research Bulletin|February 7, 2021
Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depressionDominika Siodłak, Gabriel Nowak, Katarzyna Mlyniec
Behavioural Brain Research|April 2, 2015
Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonistsKatarzyna Młyniec, Magdalena Gaweł, Gabriel Nowak
Pageof 19